NDC product
LoHist D
NDC 68047-120 · Larken Laboratories, Inc.
Key facts
| Product NDC | 68047-120 |
|---|---|
| Proprietary name | LoHist |
| Nonproprietary name | Chlorpheniramine Maleate / Pseudoephedrine HCl |
| Substances | CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | Larken Laboratories, Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC] |
| Marketing start | Sep 15, 2003 |
| Marketing end | May 21, 2030 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory